This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Shiseido Company, Limited. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Junichi Hosoi: Innovator in Skin Response Sedation
Introduction
Junichi Hosoi is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of dermatology through his innovative research and patenting efforts. His work focuses on developing agents that can effectively sedate the skin's response to external stimuli.
Latest Patents
Junichi Hosoi holds a patent for an "Agent for sedating response to external stimulation in skin and method for sedating that response." The objective of this invention is to provide a solution that mitigates the skin's reaction to external stimuli. This was achieved by identifying a component that enhances CD39 gene expression in Langerhans cells. Specifically, the invention is based on the discovery that a combination of carboxymethyl-beta glucan or a salt thereof, along with polyoxyethylene (POE)/polyoxypropylene (POP) random copolymer dimethyl ether and rosewater, promotes CD39 gene expression.
Career Highlights
Junichi Hosoi is associated with Shiseido Company, Limited, a leading global cosmetics company. His work at Shiseido has allowed him to explore innovative solutions in skincare, contributing to the company's reputation for quality and effectiveness in cosmetic products.
Collaborations
He has collaborated with notable colleagues, including Kaori Inoue and Shoko Yamada, to further advance research in skin response and sedation techniques.
Conclusion
Junichi Hosoi's contributions to the field of dermatology through his innovative patent highlight his commitment to improving skin care solutions. His work continues to influence the industry and enhance the understanding of skin responses to external stimuli.